These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 183378)

  • 21. Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection?
    Linnemann CC; Dunn CR; First MR; Alvira M; Schiff GM
    Arch Intern Med; 1978 Aug; 138(8):1247-50. PubMed ID: 209756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
    Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus and Epstein-Barr virus infection in renal transplant recipients.
    Zhao JQ; Lin T; Rabin B
    Chin Med J (Engl); 1985 Apr; 98(4):292-4. PubMed ID: 2988871
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of donor transmitted disease in cardiac transplantation.
    Hakim M; Wreghitt TG; English TA; Stovin PG; Cory-Pearce R; Wallwork J
    J Heart Transplant; 1985 May; 4(3):302-6. PubMed ID: 3039096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of renal transplants obtained from anti-HCV positive donors.
    Gómez E; Aguado S; Gago E; Martinez A; Cimadevilla R; Melón S; de Oña M; Alvarez-Grande J
    Transplant Proc; 1991 Oct; 23(5):2654-5. PubMed ID: 1656567
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific IgM of cytomegaloviruses and primary infection in kidney transplant patients].
    Devillechabrolle A; Nguyen TT; Luciani J; Frantz P; Huraux JM
    Pathol Biol (Paris); 1987 Oct; 35(8):1123-6. PubMed ID: 2825100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission of cytomegalovirus infection with renal allograft.
    Betts RF; Freeman RB; Douglas RG; Talley TE; Rundell B
    Kidney Int; 1975 Dec; 8(6):385-92. PubMed ID: 173913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytomegalovirus diseases following allogenic kidney transplantation].
    Tenschert W; Huland H
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():43-8. PubMed ID: 1334221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation.
    Waid TH; McKeown JW
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):46. PubMed ID: 7482820
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection.
    Nadasdy T; Smith J; Laszik Z; Waner JL; Johnson LD; Silva FG
    Mod Pathol; 1994 Apr; 7(3):289-94. PubMed ID: 8058700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polymerase chain reaction in diagnosis of cytomegalovirus infection in patients with organ allotransplants].
    Vediakov AM; Dolgikh MS
    Ter Arkh; 1998; 70(4):45-8. PubMed ID: 9612903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
    Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
    Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of the cytomegalovirus by the polymerase chain reaction DNA amplification in a kidney transplanted patient.
    Ergazaki M; Liloglou T; Koffa M; Kostakis A; Haliassos A; Spandidos DA
    In Vivo; 1993; 7(6A):531-4. PubMed ID: 8193272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
    Pakkala S; Salmela K; Lautenschlager I; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):283-4. PubMed ID: 1311472
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
    Chatterjee SN; Jordan GW
    Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.